Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc.
about
Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary MedicineFood-derived bioactive peptides on inflammation and oxidative stressRole of cytokines in intervertebral disc degeneration: pain and disc contentInvestigation of anti-infection mechanism of lactoferricin and splunc-1.Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc diCrocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK.Cordycepin inhibits LPS-induced inflammatory and matrix degradation in the intervertebral disc.Bovine lactoferricin-induced anti-inflammation is, in part, via up-regulation of interleukin-11 by secondary activation of STAT3 in human articular cartilageCarthamin yellow inhibits matrix degradation and inflammation induced by LPS in the intervertebral disc via suppression of MAPK pathway activation.Surgical anatomy, radiological features, and molecular biology of the lumbar intervertebral discs.Induction of Osteoarthritis-like Pathologic Changes by Chronic Alcohol Consumption in an Experimental Mouse Model.Lactoferricin enhances BMP7-stimulated anabolic pathways in intervertebral disc cells.Ghrelin protects against nucleus pulposus degeneration through inhibition of NF-κB signaling pathway and activation of Akt signaling pathway.Progranulin derived engineered protein Atsttrin suppresses TNF-α-mediated inflammation in intervertebral disc degenerative disease.Resveratrol protects against sodium nitroprusside induced nucleus pulposus cell apoptosis by scavenging ROS.Coumestrol Counteracts Interleukin-1β-Induced Catabolic Effects by Suppressing Inflammation in Primary Rat Chondrocytes.Comparison of clinical outcomes of anterior versus posterior surgery in treating multi-segmental cervical degeneration.Sesamin inhibits lipopolysaccharide-induced inflammation and extracellular matrix catabolism in rat intervertebral disc.Photobiomodulation of extracellular matrix enzymes in human nucleus pulposus cells as a potential treatment for intervertebral disk degeneration
P2860
Q26746324-557BD57A-22B9-4F7B-B1E8-D0A9D378F294Q26858862-1617B92D-FBFA-4864-BB7F-3225B451CF2CQ27001658-710A7013-9878-45E0-8F2D-04CAE044889FQ33614360-E28F098F-24D9-48FA-868F-5704AA66DC2FQ34299937-33BC111F-E32F-4ED9-8315-CDB4C12632A6Q36148587-06BD7AA9-0423-4940-A463-E5925A5F4514Q36903329-9825CA12-DB55-426E-AE5C-EF01425A92E2Q37272126-63EA0E26-DEB7-4059-86C3-B1B318E65A88Q38642143-FBEDBAD2-1551-4666-A87D-853925C3B71EQ39044506-6249C726-6EA3-4029-BE4F-190D67C0933EQ39943569-06DCACCF-DCCB-4F70-A47F-FAB7999E32F0Q42124492-95F0B679-8C02-41AB-935D-B03D01218BEBQ45981837-D84025CA-53A5-45D2-9C70-5420B46EC98FQ47220337-3E126D59-31E8-4277-8FC6-4FE737BBEEFAQ50047952-6492EA3B-1D72-4533-AEDD-88041D7C17BEQ51425285-71DC7837-6AB7-45A8-BC5D-60B9AA8A328DQ53010061-AAFE45E9-F184-444A-92BA-EF0325FDC402Q53111647-94A7A4CC-6F62-4E71-A0EE-59B878829B3EQ58802444-4D9AC31A-E5D6-419F-8015-1A1D8F7AF811
P2860
Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lactoferricin mediates anti-in ...... ty in the intervertebral disc.
@en
type
label
Lactoferricin mediates anti-in ...... ty in the intervertebral disc.
@en
prefLabel
Lactoferricin mediates anti-in ...... ty in the intervertebral disc.
@en
P2093
P2860
P356
P1476
Lactoferricin mediates anti-in ...... ty in the intervertebral disc.
@en
P2093
Andre J Van Wijnen
David W Hoskin
Dongyao Yan
Doug D Buechter
Gabriella Cs-Szabo
Guozhi Xiao
Hee-Jeong Im
Howard S An
Jae-Sung Kim
P2860
P304
P356
10.1002/JCP.24350
P577
2013-09-01T00:00:00Z